GEODE CAPITAL MANAGEMENT, LLC - CELLULAR BIOMEDICINE GROUP I ownership

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 24 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$3,473,000
+4.4%
189,011
+4.2%
0.00%0.0%
Q3 2020$3,327,000
+27.3%
181,463
+3.9%
0.00%0.0%
Q2 2020$2,613,000
+0.6%
174,606
+6.3%
0.00%0.0%
Q1 2020$2,597,000
-48.9%
164,196
-47.5%
0.00%0.0%
Q4 2019$5,078,000
+126.7%
312,782
+107.4%
0.00%0.0%
Q3 2019$2,240,000
-8.9%
150,790
+1.3%
0.00%0.0%
Q2 2019$2,459,000
+7.7%
148,815
+12.7%
0.00%0.0%
Q1 2019$2,283,000
-48.7%
132,003
-47.6%
0.00%0.0%
Q4 2018$4,452,000
+120.2%
252,134
+126.2%
0.00%0.0%
Q3 2018$2,022,000
+12.4%
111,446
+21.1%
0.00%0.0%
Q2 2018$1,799,000
+76.5%
92,023
+58.4%
0.00%
Q1 2018$1,019,000
+120.1%
58,085
+42.3%
0.00%
Q4 2017$463,000
+2.4%
40,805
-3.9%
0.00%
Q3 2017$452,000
+21.8%
42,4530.0%0.00%
Q2 2017$371,000
-48.8%
42,453
-30.9%
0.00%
Q1 2017$725,000
-8.3%
61,446
+1.7%
0.00%
Q4 2016$791,000
-4.1%
60,416
+6.2%
0.00%
Q3 2016$825,000
+24.2%
56,899
+2.7%
0.00%
Q2 2016$664,000
-31.8%
55,422
+6.1%
0.00%
-100.0%
Q1 2016$974,000
-12.3%
52,252
+1.0%
0.00%0.0%
Q4 2015$1,111,000
+30.9%
51,729
+3.2%
0.00%0.0%
Q3 2015$849,000
-40.8%
50,149
+31.1%
0.00%0.0%
Q2 2015$1,435,000
+68.8%
38,260
+41.5%
0.00%
Q1 2015$850,000
+288.1%
27,034
+58.8%
0.00%
Q4 2014$219,00017,0250.00%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q2 2017
NameSharesValueWeighting ↓
S. MUOIO & CO. LLC 52,468$964,0001.05%
Olympiad Research LP 54,795$1,007,0000.58%
Alpine Global Management, LLC 119,902$2,204,0000.45%
GABELLI & Co INVESTMENT ADVISERS, INC. 65,922$1,212,0000.19%
First Trust Capital Management L.P. 32,688$601,0000.17%
GLAZER CAPITAL, LLC 232,103$4,266,0000.15%
Walleye Capital LLC 105,000$1,930,0000.13%
Yakira Capital Management, Inc. 17,588$323,0000.08%
Dynamic Technology Lab Private Ltd 17,929$330,0000.05%
EQUITEC PROPRIETARY MARKETS, LLC 10,600$195,0000.05%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders